Copyright
©The Author(s) 2016.
World J Cardiol. Oct 26, 2016; 8(10): 584-589
Published online Oct 26, 2016. doi: 10.4330/wjc.v8.i10.584
Published online Oct 26, 2016. doi: 10.4330/wjc.v8.i10.584
% | Heart failure (n = 12) | Healthy subjects (n = 14) | P value |
Age (yr) | 66 ± 12 | 66 ± 12 | 0.994 |
Male | 67 | 36 | 0.238 |
Caucasian ethnicity | 92 | 100 | 0.462 |
LVEF | 22 ± 9 | ||
Diabetes | 33 | 0 | 0.033 |
CAD | 50 | 0 | 0.004 |
Hypertension | 25 | 29 | 1.000 |
Medications | |||
Beta-blocker | 50 | 0 | |
ACE inhibitor or ARB | 75 | 7 | |
Loop diuretic | 100 | 0 | |
ARA | 42 | 0 | |
Hydralazine/isosorbide dinitrate | 8 | 0 | |
Amiodarone | 50 | 0 | |
Digoxin | 50 | 0 |
- Citation: Ng TM, Toews ML. Impaired norepinephrine regulation of monocyte inflammatory cytokine balance in heart failure. World J Cardiol 2016; 8(10): 584-589
- URL: https://www.wjgnet.com/1949-8462/full/v8/i10/584.htm
- DOI: https://dx.doi.org/10.4330/wjc.v8.i10.584